OXE Marine - Sales picking up
2023-07-31 09:25:00
Redeye is encouraged by the improved sales in Q2. Also, gross margins were at healthy levels of 30%, when adjusting for inventory write-downs. Q2 earnings are impacted by several cost items labeled as non-recurring, hence a significant loss. But we believe the company will improve its financial performance going forward. Our overall view remains intact, and we are basically only making changes to our near-term forecasts (2023 earning).
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/